- Home
- LIMN vs MLAB Comparison
LIMN vs MLAB Comparison
Compare LIMN & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIMN
- MLAB
- Stock Information
- Founded
- LIMN 2018
- MLAB 1982
- Country
- LIMN United States
- MLAB United States
- Employees
- LIMN N/A
- MLAB N/A
- Industry
- LIMN
- MLAB Industrial Machinery/Components
- Sector
- LIMN
- MLAB Industrials
- Exchange
- LIMN NYSE
- MLAB Nasdaq
- Market Cap
- LIMN 623.8M
- MLAB 524.2M
- IPO Year
- LIMN N/A
- MLAB N/A
- Fundamental
- Price
- LIMN $16.60
- MLAB $96.36
- Analyst Decision
- LIMN
- MLAB Hold
- Analyst Count
- LIMN 0
- MLAB 2
- Target Price
- LIMN N/A
- MLAB $130.00
- AVG Volume (30 Days)
- LIMN 611.0K
- MLAB 170.9K
- Earning Date
- LIMN 01-01-0001
- MLAB 08-04-2025
- Dividend Yield
- LIMN N/A
- MLAB 0.65%
- EPS Growth
- LIMN N/A
- MLAB N/A
- EPS
- LIMN N/A
- MLAB N/A
- Revenue
- LIMN N/A
- MLAB $240,978,000.00
- Revenue This Year
- LIMN N/A
- MLAB $6.28
- Revenue Next Year
- LIMN N/A
- MLAB $5.93
- P/E Ratio
- LIMN N/A
- MLAB N/A
- Revenue Growth
- LIMN N/A
- MLAB 11.47
- 52 Week Low
- LIMN $4.40
- MLAB $83.68
- 52 Week High
- LIMN $33.66
- MLAB $155.12
- Technical
- Relative Strength Index (RSI)
- LIMN N/A
- MLAB 38.75
- Support Level
- LIMN N/A
- MLAB $95.16
- Resistance Level
- LIMN N/A
- MLAB $101.23
- Average True Range (ATR)
- LIMN 0.00
- MLAB 4.34
- MACD
- LIMN 0.00
- MLAB 0.42
- Stochastic Oscillator
- LIMN 0.00
- MLAB 46.02
About LIMN LIMINATUS PHARMA INC
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.